Cargando…
P105: Decisional role of interim PET in relapsed/refractory classical Hodgkin Lymphoma treated with four begev cycles
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621534/ http://dx.doi.org/10.1097/01.HS9.0000890988.85828.9b |
_version_ | 1784821579280023552 |
---|---|
author | Rusconi, Chiara Ricci, Francesca Zilioli, Vittorio R. Marasco, Vincenzo Calabretta, Eleonora Guidetti, Anna Muzi, Cristina Mazzon, Federico Smania, Margherita Sollini, Martina Meli, Erika Rodari, Marcello Ravano, Emanuele Cairoli, Roberto Corradini, Paolo Santoro, Armando |
author_facet | Rusconi, Chiara Ricci, Francesca Zilioli, Vittorio R. Marasco, Vincenzo Calabretta, Eleonora Guidetti, Anna Muzi, Cristina Mazzon, Federico Smania, Margherita Sollini, Martina Meli, Erika Rodari, Marcello Ravano, Emanuele Cairoli, Roberto Corradini, Paolo Santoro, Armando |
author_sort | Rusconi, Chiara |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9621534 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-96215342022-11-01 P105: Decisional role of interim PET in relapsed/refractory classical Hodgkin Lymphoma treated with four begev cycles Rusconi, Chiara Ricci, Francesca Zilioli, Vittorio R. Marasco, Vincenzo Calabretta, Eleonora Guidetti, Anna Muzi, Cristina Mazzon, Federico Smania, Margherita Sollini, Martina Meli, Erika Rodari, Marcello Ravano, Emanuele Cairoli, Roberto Corradini, Paolo Santoro, Armando Hemasphere Relapsed/Refractory Lippincott Williams & Wilkins 2022-10-03 /pmc/articles/PMC9621534/ http://dx.doi.org/10.1097/01.HS9.0000890988.85828.9b Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Relapsed/Refractory Rusconi, Chiara Ricci, Francesca Zilioli, Vittorio R. Marasco, Vincenzo Calabretta, Eleonora Guidetti, Anna Muzi, Cristina Mazzon, Federico Smania, Margherita Sollini, Martina Meli, Erika Rodari, Marcello Ravano, Emanuele Cairoli, Roberto Corradini, Paolo Santoro, Armando P105: Decisional role of interim PET in relapsed/refractory classical Hodgkin Lymphoma treated with four begev cycles |
title | P105: Decisional role of interim PET in relapsed/refractory classical Hodgkin Lymphoma treated with four begev cycles |
title_full | P105: Decisional role of interim PET in relapsed/refractory classical Hodgkin Lymphoma treated with four begev cycles |
title_fullStr | P105: Decisional role of interim PET in relapsed/refractory classical Hodgkin Lymphoma treated with four begev cycles |
title_full_unstemmed | P105: Decisional role of interim PET in relapsed/refractory classical Hodgkin Lymphoma treated with four begev cycles |
title_short | P105: Decisional role of interim PET in relapsed/refractory classical Hodgkin Lymphoma treated with four begev cycles |
title_sort | p105: decisional role of interim pet in relapsed/refractory classical hodgkin lymphoma treated with four begev cycles |
topic | Relapsed/Refractory |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621534/ http://dx.doi.org/10.1097/01.HS9.0000890988.85828.9b |
work_keys_str_mv | AT rusconichiara p105decisionalroleofinterimpetinrelapsedrefractoryclassicalhodgkinlymphomatreatedwithfourbegevcycles AT riccifrancesca p105decisionalroleofinterimpetinrelapsedrefractoryclassicalhodgkinlymphomatreatedwithfourbegevcycles AT ziliolivittorior p105decisionalroleofinterimpetinrelapsedrefractoryclassicalhodgkinlymphomatreatedwithfourbegevcycles AT marascovincenzo p105decisionalroleofinterimpetinrelapsedrefractoryclassicalhodgkinlymphomatreatedwithfourbegevcycles AT calabrettaeleonora p105decisionalroleofinterimpetinrelapsedrefractoryclassicalhodgkinlymphomatreatedwithfourbegevcycles AT guidettianna p105decisionalroleofinterimpetinrelapsedrefractoryclassicalhodgkinlymphomatreatedwithfourbegevcycles AT muzicristina p105decisionalroleofinterimpetinrelapsedrefractoryclassicalhodgkinlymphomatreatedwithfourbegevcycles AT mazzonfederico p105decisionalroleofinterimpetinrelapsedrefractoryclassicalhodgkinlymphomatreatedwithfourbegevcycles AT smaniamargherita p105decisionalroleofinterimpetinrelapsedrefractoryclassicalhodgkinlymphomatreatedwithfourbegevcycles AT sollinimartina p105decisionalroleofinterimpetinrelapsedrefractoryclassicalhodgkinlymphomatreatedwithfourbegevcycles AT melierika p105decisionalroleofinterimpetinrelapsedrefractoryclassicalhodgkinlymphomatreatedwithfourbegevcycles AT rodarimarcello p105decisionalroleofinterimpetinrelapsedrefractoryclassicalhodgkinlymphomatreatedwithfourbegevcycles AT ravanoemanuele p105decisionalroleofinterimpetinrelapsedrefractoryclassicalhodgkinlymphomatreatedwithfourbegevcycles AT cairoliroberto p105decisionalroleofinterimpetinrelapsedrefractoryclassicalhodgkinlymphomatreatedwithfourbegevcycles AT corradinipaolo p105decisionalroleofinterimpetinrelapsedrefractoryclassicalhodgkinlymphomatreatedwithfourbegevcycles AT santoroarmando p105decisionalroleofinterimpetinrelapsedrefractoryclassicalhodgkinlymphomatreatedwithfourbegevcycles |